ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Wenjuan Yin
Matched on ORCID iD 0000-0002-8637-9095; OpenAlex author ID A5059680275. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 31
2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers
Papers 6
- Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer. Co-author DOI 10.1038/s41467-024-47242-3↗
- [Expression and clinical significance of FAT1 gene in pancreatic adenocarcinoma]. Co-author DOI 10.3760/cma.j.cn112152-20231024-00214↗
- The expression profile of Gasdermin C-related genes predicts the prognosis and immunotherapy response of pancreatic adenocarcinoma. First author PMID 37168356↗
- Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis. Co-author DOI 10.1186/s12943-022-01538-4↗
- [Pathological features related to onco-immunity and their clinical significance of pancreatic ductal adenocarcinoma]. Last author DOI 10.3760/cma.j.cn112151-20210902-00641↗
- Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance. Co-author DOI 10.1038/s41467-021-27349-7↗
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jun Yao · 2 shared papers, 2021–2024 · strength 0.25
- Paper Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer. DOI 10.1038/s41467-024-47242-3↗
- Paper Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherap… DOI 10.1038/s41467-021-27349-7↗
- Mien‐Chie Hung · 2 shared papers, 2021–2024 · strength 0.25
- Paper Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer. DOI 10.1038/s41467-024-47242-3↗
- Paper Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherap… DOI 10.1038/s41467-021-27349-7↗
- Xiaodan Liu · 1 shared paper, 2024 · strength 0.20
- Dan Su · 1 shared paper, 2024 · strength 0.20
- Xiang-Hou Xia · 1 shared paper, 2023 · strength 0.17
- Jian V. Huang · 1 shared paper, 2023 · strength 0.17
- C M Wang · 1 shared paper, 2022 · strength 0.16
- Simin Qi · 1 shared paper, 2022 · strength 0.15
- Xiaoqing Guan · 1 shared paper, 2022 · strength 0.15
- Weidong Zhang · 1 shared paper, 2022 · strength 0.15
- Xiangdong Cheng · 1 shared paper, 2022 · strength 0.15
- Jiang‐Jiang Qin · 1 shared paper, 2022 · strength 0.15
- Ping Chen · 1 shared paper, 2024 · strength 0.14
- Ching-Fei Li · 1 shared paper, 2024 · strength 0.14
- Jianhua Ling · 1 shared paper, 2024 · strength 0.14
- Huamin Wang · 1 shared paper, 2024 · strength 0.14
- Ya’an Kang · 1 shared paper, 2024 · strength 0.14
- Qian Huang · 1 shared paper, 2024 · strength 0.14
- Kenei Furukawa · 1 shared paper, 2024 · strength 0.14
- Lu Yu · 1 shared paper, 2024 · strength 0.14
- Jun Zhao · 1 shared paper, 2024 · strength 0.14
- Jie Fu · 1 shared paper, 2024 · strength 0.14
- Paul J. Chiao · 1 shared paper, 2024 · strength 0.14
- Jason B. Fleming · 1 shared paper, 2024 · strength 0.14
- Anirban Maitra · 1 shared paper, 2024 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.